Legislators in the slow lane are costing lives, say drug activists
Delays in patent law reform have 'devastating consequences' as patients have to pay huge amounts for drugs sold cheaply everywhere else
A blood cancer diagnosis is bad enough, but what if one of the key treatments cost 23 times more than it does in India?
Lenalidomide is one of the drugs highlighted by campaigners who say foot-dragging by the government is denying sick South Africans access to medication widely available – and affordable – elsewhere.
The activists say delays in patent law reform have “devastating consequences” for patients with conditions such as multiple myeloma, the blood cancer for which Lenalidomide is prescribed...